HeartFlow appoints Julie Cullivan to its Board of Directors

– USA, CA –  HeartFlow, Inc., a leader in revolutionizing precision heartcare, appoints Julie Cullivan, Chief Information Officer of Forescout Technologies, Inc., to its Board of Directors, effective November 19, 2020.

“Julie’s long-time leadership in the technology and cybersecurity industry will provide substantial strategic guidance as HeartFlow continues to scale its business and provide physicians and patients with a world-class, integrated solution for coronary artery disease management,” said Board Chairman, Bill Weldon. “Julie’s unique depth of knowledge and experience of how to scale technology companies, while maintaining data security and privacy, makes her an ideal addition to HeartFlow’s Board of Directors.”

About Julie Cullivan

Ms. Cullivan has more than two decades of operational and technical experience across some of the world’s largest cybersecurity and IT brands. She has spent her career helping enterprise software and cloud companies scale their business and is a sought-after speaker on diversity and inclusion, security as a boardroom imperative, innovation, and building high-impact teams. Before Forescout, Ms. Cullivan held executive roles focused on global sales and business operations at FireEye, Autodesk, McAfee, EMC, and Oracle.

“HeartFlow is a mission-driven company that applies fascinating artificial intelligence, cloud, and security technologies to tackle coronary artery disease, the world’s leading cause of death,” said Julie Cullivan. “I look forward to bringing my software, cloud, and operational expertise to the Board so we can shape the future of cardiac care and save lives.”

In addition to HeartFlow, Ms. Cullivan serves on the Board of Directors for Axon Enterprise, Inc, and has a bachelor’s degree in finance from Santa Clara University.

About HeartFlow, Inc.

HeartFlow, Inc. is a leader in revolutionizing precision heartcare, uniquely combining human ingenuity with advanced technology. Our non-invasive HeartFlow FFRct Analysis leverages artificial intelligence to create a personalized 3D model of the heart. By using this model, clinicians can better evaluate the impact a blockage has on blood flow and determine the best treatment for patients. Our technology is reflective of our Silicon Valley roots and incorporates decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRct Analysis is commercially available in the United States, Canada, Europe, and Japan.

For more information: https://www.heartflow.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.